This conference is organised by Elsevier
Abstract submission deadline: 21 September 2018
Early registration deadline: 30 November 2018
Co-Chair: Mark S. George
Editor-in-Chief, Brain Stimulation, Medical University of South Carolina, Charleston, SC, USA
In 1995 Dr. George, a South Carolina native, returned to Charleston and built a campus-wide research brain imaging division and the brain stimulation laboratory in the Department of Psychiatry. As an undergraduate student in philosophy at Davidson College, Dr. George began studying the relationship between mind and brain, or brain/behavior relationships.
View full bio
He has continued this interest throughout his career with a focus on using brain imaging and brain stimulation to understand depression and devise new treatments. He received his medical degree from MUSC in 1985, where he continued with dual residencies in both neurology and psychiatry. He is board certified in both areas.
Following his residency training he worked for one year (1990-91) at the Institute of Neurology, Queen Square, London, England. He then moved to Washington, DC, working in the Intramural National Institute of Mental Health (NIMH). He was one of the first to use functional brain imaging during normal emotions as well as in depression and mania. He has grown the science of brain stimulation, both in terms of how the treatments work in the brain, and in critically evaluating their therapeutic applications, especially in treating depression. He may be unique in being the only living neuroscientist with 2 FDA approved treatments that stem from their work. Transcranial magnetic stimulation (TMS) was FDA approved for treating depression in October, 2008. In June 1998 at MUSC, he also pioneered another new treatment for resistant depression, vagus nerve stimulation (VNS). This was FDA approved in 2006.
He is a world expert in brain stimulation, and depression, and is the editor-in-chief of a new journal he launched with Elsevier in 2008 called, Brain Stimulation: Basic, Translation and Clinical Research in Neuromodulation. He has been continuously funded by NIH and other funding agencies since his fellowships. He has received numerous national and international awards. In 2009 US News and World Report named him one of 14 ‘medical pioneers who are not holding back’. He has published over 400 scientific articles or book chapters, and has written or edited 6 books.
Co-Chair: Harold A. Sackeim, PhD
Founding Editor, Brain Stimulation, Columbia University, New York, NY, USA
Dr. Harold A. Sackeim is Professor of Clinical Psychology in Psychiatry and Radiology, College of Physicians and Surgeons, Columbia University. He served as Chief of the Department of Biological Psychiatry at the New York State Psychiatric Institute for 25 years. He is also the founding Editor of the journal, Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation.
View full bio
He received his first B.A. from Columbia College, Columbia University (1972), another B.A. and a M.A. from Magdalen College, Oxford University (1974) and his Ph.D. from the University of Pennsylvania (1977), where he also completed his clinical training in the Department of Psychiatry. He joined the faculty of Columbia University in 1977, where he remains today.
His research has concentrated on the neurobiology and treatment of mood disorders. He has made numerous contributions to the understanding of pathophysiology of major depression and mania through use of brain imaging techniques and by examining the role of lateralization of brain function in normal emotion, neurological disorders, and psychiatric illness. For 30 years, he led the clinical research on electroconvulsive therapy (ECT) at Columbia University and the New York State Psychiatric Institute. This work has identified fundamental factors in this treatment that are responsible for its efficacy and side effects, and has radically altered understanding of both therapeutics and mechanisms of action. This research program has provided compelling evidence regarding the localization of the brain circuits involved in antidepressant effects, and has revamped understanding of the underpinnings of ECT’s effects on mood, behavior, and cognition. Dr. Sackeim is widely credited with transforming the use of this treatment worldwide. Dr. Sackeim has directed programs at the New York State Psychiatric Institute and New York Presbyterian Hospital in the pharmacological treatment of late-life depression, and in the use of Transcranial Magnetic Stimulation (TMS), Vagus Nerve Stimulation (VNS), Deep Brain Stimulation (DBS) and other forms of focal brain stimulation. Dr. Sackeim is the inventor of Magnetic Seizure Therapy (MST), now undergoing clinical trials and has recently developed FEAST (Focal Electrically-Administered Seizure Therapy. Dr. Sackeim introduced functional brain imaging to the medical center at Columbia in 1980, and directed a large group using Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) to study pathophysiology and treatment effects in mood disorders, anxiety disorders, Lyme disease, substance abuse, Alzheimer’s disease, and normal aging. Other work directed by Dr. Sackeim involved preclinical, primate research on the functional significance of structural brain changes (neurogenesis) induced by different forms of brain stimulation.
Dr. Sackeim is a member of the editorial board of several journals, and has received many national and international awards for his research contributions. These include three Distinguished Investigator Awards from the National Association for Research in Schizophrenia and Depression (NARSAD), a MERIT Award from the National Institute of Mental Health (NIMH), the Joel Elkes International Award from the American College of Neuropsychopharmacology (ACNP), election as Honorary Fellow of the American Psychiatric Association, and the Award for Research Excellence from the New York State Office of Mental Hygiene, Edward Smith Lectureship, National Institute of Psychobiology, Israel, the lifetime achievement award form the EEG and CNS Society, and the NARSAD Maddox Falcone Prize for lifetime achievement in research on affective disorders. He is past President of the Society of Biological Psychiatry and the Association for Research in Nervous and Mental Disease. He has authored more than 425 publications.
The City College of New York, NY, USA
Marom Bikson, is a Cattell Professor of Biomedical Engineering at The City College of New York (CCNY) of the City University of New York (CUNY) and co-Director of the Neural Engineering Group at the New York Center for Biomedical Engineering.
View full bio
The translational R&D activity of his group spans pre-clinical studies, computational models, device design and fabrication, regulatory activities, and clinical trials. Technologies developed by his group are in clinical trials in over 100 medical centers and include neuromodulation interventions for neuropsychiatric disorders, intra- and post-operative sensors, patient compliance tools, and surgeon training simulators. Dr. Bikson has published over 200 papers and book-chapters and is inventor on over 30 patent applications. He is known for his work on brain targeting with electrical stimulation, cellular physiology of electric effects, and electrical safety. Dr. Bikson co-invented High-Definition transcranial Direct Current Stimulation (HD-tDCS), the first non-invasive, targeted, and low-intensity neuromodulation technology. Dr. Bikson consults for medical technology companies and regulatory agencies on the design, validation, and certification of medical instrumentation. Dr. Bikson is co-founder of Soterix Medical Inc. and WiPOX LLC. Prior to becoming faculty at CUNY, Dr. Bikson was a research fellow at the University of Birmingham Medical School, UK and a Research Associate at Sontra Medical LLC, in Cambridge Mass. Dr. Bikson received a Ph.D. in Biomedical Engineering from Case Western Reserve University, in Cleveland OH, and a B.S. in Biomedical Engineering from Johns Hopkins University, Baltimore MD.
Paul Fitzgerald, MBBS, PhD
Monash Alfred Psychiatry Research Centre, The Alfred and Monash University Central Clinical School, Melbourne, Victoria, Australia
Professor Paul Fitzgerald is Professor of Psychiatry, Deputy Director and Consultant Psychiatrist at the Monash Alfred Psychiatry Research Centre, a joint research centre of Monash University and the Alfred Hospital in Melbourne, Australia.
View full bio
He runs a research program focussed on the conduct of investigative studies of brain function & dysfunction as well as the conduct of a variety of novel clinical trials in Mood, Anxiety, Psychotic and Developmental Disorders. He has published over 250 papers and received grant funding from a range of Australian and international organisations.
Zelma Kiss, MD, PhD,
University of Calgary, Calgary, Canada
More information coming soon
Randolph J. Nudo, PhD
University of Kansas Medical Center, Kansas City, USA
Randolph J. Nudo, Ph.D. is Vice Chair of Research in the Department of Rehabilitation Medicine, the Marian Merrell Dow Distinguished Professor in Aging, and Director of the Landon Center on Aging.
View full bio
Dr. Nudo is a leading authority on the topic of brain plasticity and recovery after injury. He is recognized internationally for his work on the effects of physiotherapy on functional plasticity after stroke. Dr. Nudo is currently collaborating with engineers to develop micro implantable devices for repairing neural circuits after stroke, traumatic brain injury and spinal cord injury. Dr. Nudo is also the Editor-in-Chief of the journal, Neurorehabilitation & Neural Repair, the top journal in the field of rehabilitation (based on impact factor), and Deputy Editor of Brain Stimulation. He currently serves as a member of the National Advisory Committee for Medical Rehabilitation Research.
John Rothwell, PhD
University College London, Queen Square, London, UK
After a PhD at the University of London, John Rothwell, became a Senior Scientist in the MRC Human Movement and Balance Unit at the Institute of Neurology.
View full bio
He was Head of the Sobell Department of Motor Neuroscience and Movement Disorders at the UCL Institute of Neurology from 2001-2005, and is currently Professor of Human Neurophysiology. Research projects include using neurophysiological techniques to study the mechanisms of neural plasticity that underpin motor learning, and using this knowledge to devise new therapeutic interventions for rehabilitation after stroke.
Josep Valls-Solé, MD
Hospital Clínic, University of Barcelona, Spain
Born near Barcelona, 65 years ago, I am presently a Senior Consultant in the Neurology Department of the Hospital Clinic of Barcelona, Spain, Professor and Teaching Coordinator for Neurology at the University of Barcelona, Head of the Research Group of Neurophysiology of the IDIBAPS, Scientific Advisor for the Institute Guttmann of Neurorehabilitation, Associate Editor for the journal Clinical Neurophysiology Practice and Deputy Editor for Brain Stimulation.
View full bio
My research focuses on clinical neurophysiology, motor control and pain perception. I have published more than 250 manuscripts (current H index 34) and more than 50 book chapters. I have been awarded 4 national prices and received 20 national research grants.
Vincent Walsh, PhD
University College London, London, UK
More information coming soon
Ulf Ziemann, MD
University of Tuebingen, Tuebingen, Germany
Director of the Department of Neurology and Stroke, and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Germany. Special expertise: Motor cortex excitability and plasticity, motor learning, non-invasive brain stimulation.
View full bio
Deputy Editor of "Brain Stimulation", "Clinical Neurophysiology" and "Frontiers in Human Neuroscience". Awards: Richard-Jung Prize of the German Society of Clinical Neurophysiology, Merit Award of the National Institute of Health. 275 peer-reviewed publications, h-index 67.
Local Organizing Committee
- Committee Chair: Fidel Vila-Rodriguez, MD, FAPA, FRCPC, Assistant Professor, Psychiatry, University of British Columbia, Canada
Interests: Clinician scientist, psychiatrists, clinical trials and study of biomarkers, imager. rTMS, ECT, tDCS and ECS.
- Lara Boyd, PT, PhD, Professor, Physical Therapy, University of British Columbia, Canada
Interests: Mechanistic studies using TMS as a probe; motor system; also imaging (DTI and fMRI). Stroke, PD are main areas of interest.
- Doris J. Doudet, PhD, Professor, Dept. Medicine/Neurology, University of British Columbia, Canada
Interests: Basic scientist, animal/NHP studies in neurology (PD) but also in depression. ECS, TMS. PET imager
- Faranak Farzan, PhD, School of Mechatronic Systems Engineering, Simon Fraser University, Canada, Chair in Technology Innovation for Youth Addiction Recovery and Mental Health
Interests: Electrical engineer, neurophysiologist: TMS-EEG, but also neurophysiological studies in the context of other
- Martin McKeown, MD, BEng, FRCPC, Professor, Neurology, Purdy Pavillion University Hospital, Canada
Interests: Clinician-scientist, neurologist, expertise in PD. galvanic nerve stimulation, some TMS. neuroimager.